Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$92.88 USD

92.88
6,636,881

+1.64 (1.80%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $92.94 +0.06 (0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (155 out of 244)

Industry: Medical - Products

Zacks News

Zacks Equity Research

Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know

Medtronic (MDT) closed at $85.54 in the latest trading session, marking a +1.05% move from the prior day.

Zacks Equity Research

Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It

Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

Zimmer Biomet (ZBH) Surpasses Q3 Earnings and Revenue Estimates

Zimmer (ZBH) delivered earnings and revenue surprises of 1.28% and 2.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Medtronic (MDT) Gains As Market Dips: What You Should Know

In the latest trading session, Medtronic (MDT) closed at $87.34, marking a +0.6% move from the previous day.

Zacks Equity Research

Medtronic (MDT) Gains But Lags Market: What You Should Know

Medtronic (MDT) closed at $84.50 in the latest trading session, marking a +0.74% move from the prior day.

Zacks Equity Research

Medtronic (MDT) Gains But Lags Market: What You Should Know

Medtronic (MDT) closed at $83.88 in the latest trading session, marking a +0.74% move from the prior day.

Zacks Equity Research

Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.

Zacks Equity Research

This 1 Medical Stock Could Beat Earnings: Why It Should Be on Your Radar

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

Medtronic (MDT) Gains But Lags Market: What You Should Know

In the latest trading session, Medtronic (MDT) closed at $82.76, marking a +1.41% move from the previous day.

Zacks Equity Research

Medtronic (MDT) Gains As Market Dips: What You Should Know

Medtronic (MDT) closed the most recent trading day at $81.89, moving +0.06% from the previous trading session.

Zacks Equity Research

Green Thumb Industries Inc. (GTBIF) Soars 30.3%: Is Further Upside Left in the Stock?

Green Thumb Industries Inc. (GTBIF) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Equity Research

Medtronic (MDT) Gains As Market Dips: What You Should Know

Medtronic (MDT) closed at $85.05 in the latest trading session, marking a +0.65% move from the prior day.

Zacks Equity Research

Here is What to Know Beyond Why Medtronic PLC (MDT) is a Trending Stock

Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

Medtronic (MDT) Stock Moves -0.39%: What You Should Know

In the latest trading session, Medtronic (MDT) closed at $82.27, marking a -0.39% move from the previous day.

Zacks Equity Research

Medtronic (MDT) Down 4% Since Last Earnings Report: Can It Rebound?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Medtronic (MDT) Gets FDA's 510(k) Nod for Pediatric ICM

This latest approval broadens Medtronic's scope within its Cardiovascular Diagnostics and Services wing within broader Cardiovascular business.

Zacks Equity Research

Is Trending Stock Medtronic PLC (MDT) a Buy Now?

Recently, Zacks.com users have been paying close attention to Medtronic (MDT). This makes it worthwhile to examine what the stock has in store.

Zacks Equity Research

Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?

Sector ETF report for IHI

Zacks Equity Research

Is Most-Watched Stock Medtronic PLC (MDT) Worth Betting on Now?

Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

The Zacks Analyst Blog Highlights Visa, Broadcom, Medtronic, Walt Disney and BP

Visa, Broadcom, Medtronic, Walt Disney and BP are part of The Zacks top Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Visa, Broadcom & Medtronic

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Broadcom Inc. (AVGO) and Medtronic plc (MDT).

Zacks Equity Research

Medtronic (MDT) Obtains U.S. Distribution Rights for BioButton

Medtronic's (MDT) new deal with BioIntelliSense will ensure accessibility to BioButton for continuous vital sign measurements of general care patients in the United States.

Zacks Equity Research

Medtronic (MDT) Q1 Earnings Beat Estimates, Margins Down

Medtronic (MDT) posts better-than-expected results for the fiscal first quarter and maintains earnings and sales outlook for the full year.

Zacks Equity Research

Medtronic (MDT) Q1 Earnings and Revenues Surpass Estimates

Medtronic (MDT) delivered earnings and revenue surprises of 0.89% and 2.34%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Haemonetics (HAE) Hits 52-Week High: What's Aiding the Stock?

Investors are optimistic about Haemonetics' (HAE) potential in its Plasma franchise.